Structural dynamics and physicochemical properties of pDNA/DODAB:MO lipoplexes : effect of pH and anionic lipids in inverted non-lamellar phases versus lamellar phases by Silva, João P. N. et al.
Biochimica et Biophysica Acta 1838 (2014) 2555–2567
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamemStructural dynamics and physicochemical properties of pDNA/DODAB:
MO lipoplexes: Effect of pH and anionic lipids in inverted non-lamellar
phases versus lamellar phasesJ.P. Neves Silva a, I.M.S.C. Oliveira a, A.C.N. Oliveira a,b, M. Lúcio a, A.C. Gomes b,
P.J.G. Coutinho a, M.E.C.D. Real Oliveira a,⁎
a CFUM (Centre of Physics of the University of Minho), Department of Physics, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal
b CBMA (Centre of Molecular and Environmental Biology), Department of Biology, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal⁎ Corresponding author. Tel.: +351 253 604 325; fax: +
E-mail address: beta@ﬁsica.uminho.pt (M.E.C.D.R. Oliv
http://dx.doi.org/10.1016/j.bbamem.2014.06.014
0005-2736/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 7 March 2014
Received in revised form 17 June 2014
Accepted 18 June 2014
Available online 27 June 2014
Keywords:
Lipoplexes
Nile Red
FRET
Light scattering
Cryo-TEM
TransfectionDioctadecyldimethylammonium bromide (DODAB):Monoolein (MO) lipoplexes havemainly been studiedwith-
in the range of high molar ratios of DODAB, with noticeable transfection efﬁciencies in the Human Embryonic
Kidney (HEK, a.k.a. 293T) cell line. In thiswork, we intend to study the effect of highMO content on the structure
and physicochemical properties of pDNA/DODAB:MO lipoplexes to achieve some correlation with their transfec-
tion efﬁciency. Static/Dynamic Light Scattering and Cryo-TEM imaging were used to characterize the size/
morphology of DNA/DODAB:MO lipoplexes at different DODAB:MO contents (2:1, 1:1, 1:2) and charge ratios
(CRs) (+/−). Nile Red ﬂuorescence emission was performed to detect changes in microviscosity, hydration
and polarity of DNA/DODAB:MO systems. Lipoplexes stability at physiological pH values and in the presence of
anionic lipids was evaluated by Förster Resonance Energy Transfer (FRET). Physicochemical/structural data
were complemented with transfection studies in HEK cells using the β-galactosidase reporter gene activity
assay. This work reports the coexistence of multilamellar and non-lamellar inverted phases in MO-richer
lipoplexes (DODAB:MO 1:2 and 1:4), leading to transfection efﬁciencies comparable to those of multilamellar
(DODAB-richer) lipoplexes, but at higher charge ratios [CR (+/−) = 6.0] and without dose-effect response.
These results may be related to the structural changes of lipoplexes promoted by high MO content.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The progress of gene therapy in the last few decades has been
achieved mostly through the development of stable carriers, capable of
condensing genetic material and withstanding the harsh destabilizing
conditions of the biological environment [1–8]. Although having attained
high rates of cell internalization, these carriers have limited release of
genetic material into the cytoplasm, which explains their relatively low
cell transfection efﬁciency [9,10]. For the particular case of liposome-
based carriers, the inclusion of non-lamellar forming lipids (also called
helper lipids) in the liposomal formulations has been one of the strategies
chosen to overcome this problem. This approach potentiates the
formation of membrane fusion intermediates that disrupt the lamellar
organization of cationic liposome/DNA complexes (lipoplexes), and
favor the release of its genetic content [11,12]. Molecules such as
dioleoylphosphatidyl ethanolamine (DOPE) and cholesterol (Chol) have
been employed as successful helper lipids in several liposomal formula-
tions, enhancing the lipofection efﬁciency through the formation of351 253 678 981.
eira).inverted hexagonal structures (HII) [7,13–15]. Equimolar proportions of
cationic and helper lipids are required to develop lamellar-structured
lipoplexes that are capable of transitioning to an inverted hexagonal
phase upon pH decrease during endocytosis, thus favoring the destabili-
zation of the endosomal membrane and the release of the genetic mate-
rial into the cytoplasm [16].
Recent studies have associated synthetic tensioactives, such as 1,2-
dioleoyl-sn-glycero-3-hexylphosphocholine (C6-DOPC) and 1,2-
dierucoyl-sn-glycero-3-ethylphosphocholine (di22:1-EPC), and the
natural surfactant Monoolein (MO), with the formation of inverted
mesophases in cationic lipoplexes [17–20]. The enhancement in cell
transfection efﬁciency observed for formulations based on these type
of surfactants has been correlated with the promotion of inter-
lamellar attachments (ILAs) and packing defects, that destabilizes the
lamellar arrangement of cationic lipoplexes and favors nucleic acid
release from the lipoplex structure upon membrane fusion [21,22]. For
the nucleic acid (NA)/cationic liposome formulation composed by the
synthetic cationic lipid dioctadecyldimethylammonium bromide
(DODAB) and the non-ionic and non-lamellar forming lipid MO, the
appearance of such non-lamellar inverted mesophases seems to only
occur at equimolar or exceeding molar fractions of the helper lipid MO
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exceeding molar fractions of DODAB, where a multilamellar organiza-
tion is predominant [23]. In this work, we studied the behavior
of pDNA/DODAB:MO lipoplexes at high MO contents (1:2 and 1:4
DODAB:MO ratios), where inverted bicontinuous non-lamellar phases
aremore likely to form and remain stabilized [24]. The physicochemical
properties, destabilization dynamics and transfection efﬁciency of the
mixtures were determined and compared with DNA/DODAB:MO (2:1)
lipoplexes (multilamellar organization).
Nile Red ﬂuorescence emission and anisotropy were used to detect
variations in the microviscosity, hydration and polarity of these
systems, eventually caused by the presence of MO and/or DNA in the
lipoplexes. The hydrophobic nature of this ﬂuorescent probe and the
strong dependence of its steady-state emission with the local microen-
vironment where it is located have already been used in the physico-
chemical characterization of several lipid mixtures, including DODAB:
MO aggregates in the absence of DNA [25]. Another ﬂuorescence tech-
nique, speciﬁcally FRET, was used to monitor conformational changes
in the structure of DNA/DODAB:MO lipoplexes upon charge ratio
(+/−) increase and MO content variation. The chosen acceptor/donor
pair of ﬂuorescent probes BOBO-1 and Rhodamine-DHPE was also
employed to observe the effects of pH decrease and interactionwith an-
ionic/neutral lipids on theDNA compactionwithin the lipoplexes. These
are two of the main factors involved in lipoplex degradation during
endosomal escape, which is a strong limitation for the transfection efﬁ-
ciency of the lipoplexes.
Fluorescence spectroscopy data was complemented with 90° Static
Light Scattering (90° SLS), Dynamic Light Scattering (DLS) and cryo-
Transmission Electron Microscopy (cryo-TEM), in order to analyze the
reorganization of the structure during lipoplex formation and destabili-
zation, with special emphasis to the inverted non-lamellar phases of
pDNA/DODAB:MO (1:2 and 1:4) formulations. Finally, the transfection
efﬁciency of DNA/DODAB:MO lipoplexes (2:1, 1:1, 1:2, 1:4) on the
Human Embryonic Kidney (HEK) 293T cell line was correlated with
the structure of the lipoplexes.
2. Materials and methods
2.1. Reagents
The lipid surfactants 1-monoolein (MO) and dioctadecyldimethyl-
ammonium bromide (DODAB) were purchased, respectively, from
Sigma-Aldrich and Tokyo-Kasei. The tensioactives oleic acid (OA),
dioleoylphosphatidic acid (DOPA), dioleoylphosphatidylglycerol
(DOPG) and dioleoylphosphatidylethanolamine (DOPE) were pur-
chased from Avanti Polar Lipids. The solvatochromic/anisotropyA B C D
Fig. 1. Molecular structures of the lipids used in this study. A) Dioctadecyldimethy
Dioleoylphosphatidylethanolamine (DOPE); E) Dioleoylphosphatidylserine (DOPS); F)probe 9-(diethylamino)-5H-benzo[a]phenoxazin-5-one (Nile Red),
the lipid probe triethylammonium 5-(N-(2-(((2,3-bis(palmitoyloxy)
propoxy)oxidophosphoryl)oxy)ethyl)sulfamoyl)-2-(6-(diethylamino)-
3-(diethyliminio)-3H-xanthen-9-yl)benzenesulfonate (Rhodamine-
DHPE) and the DNA intercalating probe 2,2′-((1,1′-((propane-1,3-
diylbis(dimethylammonionediyl))bis(propane-3,1-diyl))bis(pyridin-
1(1H)-yl-4(1H)-ylidene))bis(methanylylidene))bis(3-methylbenzo[d]
thiazol-3-ium) iodide (BOBO-1) were purchased from Sigma-Aldrich.
Salmon sperm DNA was purchased from Invitrogen. All reagents were
used in the same conditions as received. The surfactant molecules
used in this study are shown in Fig. 1.2.2. Liposome preparation
For ﬂuorimetric assays involving either Nile Red (ﬂuorescence an-
isotropy) or Rhodamine-DHPE (FRET), predeﬁned volumes of the
probes were ﬁrst transferred to an Eppendorf. The solvent was evapo-
rated under a nitrogen steam, originating a probe ﬁlm that was re-
solubilized with the appropriate volume of DODAB and MO (20 mM
stock solutions in ethanol). The ﬁnal ratio probe/lipid (mol/mol) for
Nile Red and Rhodamine DHPE was kept, respectively, to 1:500 and
1:200.
The lipid solutions (either with or without the ﬂuorescence probes)
were injected under vigorous vortex to an aqueous buffer solution of
Tris-HCl (30mM) at 70 °C. Liposome solutionswith a ﬁnal lipid concen-
tration ([DODAB:MO]) of 1 mM and different DODAB:MO molar ratios:
2:1, 1:1, 1:2 and 1:4 were produced.2.3. Lipoplex preparation
Lipoplexes were prepared by adding the DODAB:MO cationic li-
posomes in an instant-mixing procedure (25 °C) to a DNA buffered
solution (20 μM). The time duration of the lipoplex formation pro-
cedure depended on the type of physicochemical characterization
technique that was used. For DLS, 90° SLS, Zeta Potential and
Cryo-TEM assays, the lipoplex incubation period was set to 30
min. For ﬂuorometric experiments involving either FRET or Nile
Red Fluorescence, the stabilization time for each data point in-
volved in the same experiment was 5 min, so that the ﬁnal incuba-
tion period was equal to the cumulated time of all consecutive data
points. The lipoplexes were generated with ammonium/phosphate
charge ratios (CRs) (+/−) between 0.0 and 4.0. The concentration
of nucleotide bases (determined by the DNA absorption at wave-
length 260 nm [26]), was held constant at 4.2 × 10−5 M in all
experiments.E F G
lammonium bromide (DODAB); B) 1-Monoolein (MO); C) Oleic Acid (OA); D)
Dioleoylphosphatidic Acid (DOPA); G) Dioleoylphosphatidylglycerol (DOPG).
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In vitro simulation of the main factors involved in DNA/DODAB:
MO lipoplex degradation during endosomal escape process was
performed by FRET analysis, upon the addition of different anion-
ic/neutral lipids to lipoplexes and also through the acidiﬁcation of
a non-buffered aqueous solution of lipoplexes with HCl. For anion-
ic/neutral lipid addition, DOPG:DOPA (1:1), DOPG:DOPS (1:1),
DOPG:DOPE (1:1) and DOPG:OA (1:1) lipid aggregates (from now
on, termed DOPA, DOPS, DOPE and OA aggregates, respectively,
for a matter of simpliﬁcation) were prepared by ethanol injection
method. The lipid aggregates were then progressively added to
DNA/DODAB:MO labeled lipoplexes (see section 2.6) at CR (+/−) =
4.0 in Tris-HCl (30mM), until a ﬁnal lipid concentration of approximately
200 μM. For the pH acidiﬁcation assay, the labeled lipoplexes were ﬁrst
prepared at the same CR (+/−)=4.0 in ultrapurewater, and then titrat-
ed with HCl (1 mM).
2.5. Nile Red ﬂuorescence emission and anisotropy assays
It is known that the maximum wavelength of Nile Red emission
spectrum increases with the polarity of the environment [27]. Addi-
tionally, Nile Red ﬂuorescence lifetime decreases with the increase
of the hydrogen bonding capability of the medium [28]. For Nile
Red assays, 2500 μL of salmon sperm DNA solution (20 μM) was
placed in a cuvette and then incubated for 5 min, under agitation,
with deﬁned volumes of the liposomal mixtures with Nile Red, to
obtain the intended ammonium/phosphate charge ratio CR (+/−).
The polarized emission spectra for Nile Red were then recorded in
a Horiba Jobin Yvon Spex Fluorolog 3 spectroﬂuorometer using
Spex polarizers with λexc at 525 nm. All spectra were corrected for
the instrumental response of the system, and the solvent back-
ground was subtracted.
A two-state model for excited state behavior of Nile Red involving a
solvent relaxation process, where A* and B* represent the initially excited
and the relaxed excited state, with the possibility of a reversible reaction
(Khrishna model [27]) was assumed:
ð1Þ
The emission spectra of Nile Red were obtained from anisotropy mea-
surements [29]:
Itotal ¼ IVV þ 2  G  IVHð Þ ð2Þ
whereG, equivalent to the ratio IHV/IHH, is the internal correction factor for
the sensitivity of the spectroﬂuorometer for vertically (V) and horizontal-
ly (H) polarized light. The corresponding anisotropy spectra are given by:
r λð Þ ¼ IVV−G:IVH
IVV þ 2:G:IVH
ð3Þ
(IVV) and (G × IVH) were simultaneously ﬁtted to a sum of two lognormal
functions [29]:
IVV=VH ¼
AVV=VH
 
1
λ− λmaxð Þ1 þ a
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ð4ÞwhereA is themaximumemission intensity atλmax, and theparameters a,
b and c are given by [29]:
a ¼ H  ρ
ρ2−1
ð5Þ
b ¼ H  ρ
ρ2−1
 exp c2
 
ð6Þ
c ¼ ln ρð Þﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2  ln 2ð Þp ð7Þ
where, H and ρ are, respectively, the halfwidth and skewness of the band.
Only the parameters with VV or HH subscript depend onwhether (IVV) or
(G × IVH) spectra are being ﬁtted. The steady-state ﬂuorescence anisot-
ropies of initially excited state (r1) and solvent relaxed state (r2), as well
as the emission intensity fraction of the initially excited state (f1) are
given by [29]:
r1 ¼
AVVð Þ1− AVHð Þ1
AVVð Þ1 þ 2  AVHð Þ1
ð8Þ
r2 ¼
AVVð Þ2− AVHð Þ2
AVVð Þ2 þ 2  AVHð Þ2
ð9Þ
f 1 ¼
AVVð Þ1 þ 2  AVHð Þ1
AVVð Þ1 þ 2  AVHð Þ1 þ AVVð Þ2 þ 2  AVHð Þ2
: ð10Þ
2.6. Förster resonance energy transfer (FRET) assays
Förster resonance energy transfer (FRET) is a non-radiative transfer
process of the excitation energy from a donor to an acceptor chromo-
phore, that is mediated by a long-range dipole–dipole interactions (För-
ster) [30]. The Förster resonance energy transfer efﬁciency (ΦFRET) is
given by the following equation [31]:
ϕFRET ¼
1
1þ rDA=Roð Þ6
ð11Þ
where (Ro) is the critical radius of Förster at which the energy transfer
and the spontaneous decay of the excited donor are equally probable
(50%), and (rDA) is the distance between donor and acceptor species
[31]. For the FRET assays performed in this study, 2500 μL of salmon
sperm DNA solution at 25°C (20 μg/μL) labeled with BOBO-1 (ratio
probe/phosphate = 1/100 mol/mol) was added to a cuvette and then
incubated for 5 min, with agitation, with deﬁned volumes of the appro-
priate liposomal mixtures containing rhodamine-DHPE (ratio probe/
lipid = 1/200 mol/mol), to obtain the intended ammonium/phosphate
charge ratio CR (+/−). The ﬂuorescence emission spectra (470–700
nm) were then recorded in a Horiba Jobin Yvon Spex Fluorolog 3 spec-
troﬂuorometer with λexc of 460 nm. All spectra were corrected for the
instrumental response of the system, and the solvent background was
subtracted. The Förster resonance energy transfer efﬁciency (ΦFRET)
was determined through the following equation:
ΦFRET ¼ 1−
ΦD
Φ0D
¼ 1− A λDð Þ
AD λDð Þ
ID λD;λ
em
D
 
I0D λD;λ
em
D
  ð12Þ
where (ΦD0) and (ΦD) are the donor quantum yields in the absence and
presence of acceptor, respectively. Eq. (12) is valid when there is negli-
gible emission from the acceptor. In the assays performed with the
donor/acceptor pair BOBO-1/rhodamine DHPE, the factor [A(λD) /
AD(λD)] has been considered equivalent to 1 due to its neglectable
2558 J.P.N. Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2555–2567contribution to the overall absorption at the excitationwavelength (λD)
(see Supplementary material 1). After the determination of (ΦFRET)
through Eq. (12), this parameter was followed upon the destabilization
of DNA/DODAB:MO CR (+/−) = 4.0 lipoplexes by pH decrease and
neutral/anionic lipid addition.
2.7. 90° Static light scattering (90° SLS) assays
The 90° SLS assays were performed for all CRs (+/−) in a Horiba
Jobin Yvon Spex Fluorolog 3 spectroﬂuorometer, with the scattering in-
tensities being recorded in timescans of 60 s each, with excitation and
emission monochromators set respectively to 600 and 601 nm, at
which there is neither absorbance, nor ﬂuorescence emission.
2.8. Dynamic light scattering (DLS) assays
DNA/DODAB:MO lipoplexes with different MO contents (2:1, 1:1,
and 1:2) were prepared at charge ratios CR (+/−) = 0.25, 0.5, 0.75,
1.0, 1.5, 2.0 and 4.0 and placed in disposable polystyrene cuvettes for
DLS measurements in a Malvern Zetasizer Nano ZS particle analyzer.
Malvern Dispersion Technology Software (DTS)was used withmultiple
narrow mode (high resolution) data processing, enabling the recovery
of the mean size (nm) and associated error values.
2.9. Cryo-TEM assays
For cryo-TEM studies, cryo-TEMgridswere prepared following stan-
dard procedures. 3 μL of lipoplexes at 1.2 mg/mL in Tris-HCl buffer solu-
tion (pH 7.4) was placed onto 200-mesh holey EM grids and vitriﬁed in
liquid ethane at liquid nitrogen temperature using a Vitrobot (FEI).
Cryo-TEM grids were observed at liquid nitrogen temperature on a
FEG JEM2200-FS/CR transmission electron microscope (JEOL) operated
at 200 kV. Digital images were recorded on a 4 K × 4 K CCD camera
Ultrascan4000™ (GATAN) under low-dose conditions and using
DigitalMicrograph™ (GATAN) software in binned mode. An in-column
omega energy ﬁlter helped to record images with improved signal to
noise ratio by zero-loss ﬁltering. The energy selecting slit width was
set at 9 eV. The images presented here were taken using the nominal
magniﬁcation of 50,000 resulting in a ﬁnal pixel size of 4.3 Å with a
defocus value ranging from −3 to −1 μm. The total electron doses
were on the order of 7–20 electrons/Å2.
2.10. Cell culture and transfection assays
The 293T cell line was cultured in DMEM complete growthmedium
(10% (v/v) heat-inactivated FBS and penicillin/streptomycin/
amphotericin B (10,000 units/10 mg/25 μg per mL)), and cells were
sub-cultured every two days in order to maintain sub-conﬂuency.
293T cells were seeded into 24-well plates and incubated overnight
at 37 °C, 5% CO2. Immediately before transfection, the cell culture medi-
um was replaced and 100 μL of the lipoplex solutions (DODAB:MO 2:1,
1:1, 1:2 and 1:4) was added to each well. After a 48 h period of incuba-
tion, β-galactosidase activity was evaluated with the β-Galactosidase
Enzyme Assay Systemwith Reporter Lysis Buffer, according to the stan-
dard protocol [32]. Lipofectamine™ LTX Reagent was used as a control,
according to manufacturer's instructions. Data from three independent
experiments were considered to identify differences across the various
formulations.
3. Results & discussion
3.1. Microviscosity/hydration changes of DODAB:MO formulations with
different MO content and upon the presence of DNA
Nile Red is a hydrophobic and solvatochromic probe that presents a
well-known dependence of its steady-state emission properties withthe polarity and the hydration level of the medium [29,33]. This probe
usually exhibits an increase in ﬂuorescence yield with decreasing sol-
vent polarity, with a corresponding blue shift in the peak emission
[27]. Moreover, the ﬂuorescence lifetime of Nile Red decreases with
the increase of H-bonding capability of themedium [28], thus reporting
on the level of hydration of themembrane. Therefore, this probewas se-
lected to report the inﬂuence of both the presence of DNA and an in-
creasing content of MO in the physicochemical properties of DNA/
DODAB:MO lipoplexes (such as microviscosity, hydration and polarity)
and also to achieve some correlation between the lipoplex physico-
chemical properties and their transfection efﬁciency [19]. Fig. 2 shows
the total ﬂuorescence intensity of Nile Red normalized to lipid concen-
tration on DNA/DODAB:MO (2:1, 1:1 and 1:2) lipoplexes as a function
of CR (+/−).
As the probe:lipid molar ratio was kept constant at a value of
1:500 (mol:mol), it was expected that Nile Red ﬂuorescence would
be constant when divided by concentration. However, at low CR
(+/−) (b0.6), variations in Nile Red ﬂuorescence emission were ob-
served, suggesting structural changes of the aggregates dependent
on the total lipid concentration and on DODAB:MO molar ratio.
This may be explained by the presence of pre-vesicular structures
at low lipid concentrations, as already detected on mixtures of
DODAB and MO in the absence of DNA [25]. In fact, when Nile Red
ﬂuorescence emission in the DODAB:MO lipoplexes (with DNA) is
divided by Nile Red ﬂuorescence emission in the DODAB:MO aggre-
gates (without DNA) (Fig. 2B), the ﬂuorescence emission remains
constant, only exhibiting a peaked behavior around CR (+/−) =
1.0 for the system DODAB:MO (1:1), and around CR (+/−) = 1.3
for DODAB/MO (1:2), being absent in the system with less MO con-
tent (2:1). This peaked behavior occurs near the neutralization
point of lipoplex assembly, and corresponds to the extensive lipid
mixing that triggers the appearance of highly organized structures
(sandwich-type, hexagonal or inverted bicontinuous cubic struc-
tures) with different levels of hydration and polarity [8,20,34].
The emission spectra of Nile Red in DNA/DODAB:MO systems
with different molar ratios (2:1, 1:1 and 1:2) and four different
CRs (+/−) (A = 0.20; B = 0.50; C = 1.00; and D = 2.00) are rep-
resented in Fig. 3.
An increase in ﬂuorescence emission with MO content for all charge
ratios is observable in Fig. 3. This variation, seen for CRs (+/−) up to 0.5,
is the same as previously observed for DODAB:MO systems in the ab-
sence of DNA and with low MO content [25]. The observed increase in
ﬂuorescence emission of Nile Red points to a decrease in hydration, pos-
sibly due to a reduction in the contact between the probe and the aque-
ous surrounding, thus suggesting closer contact between the probe and
inverted non-lamellar phase formed byMO enriched domains enclosed
by DODAB bilayers.Moreover, as seen in Fig. 2, the ﬂuorescence intensi-
ty of the probe increases with CR (+/−) increase. This can be explained
by the DNA coating of liposomes, that results in less hydrated DODAB:
MO bilayer structures. The dehydration of both DNA and lipids is an im-
portant requirement to obtain a tight contact during their interaction,
and a similar decrease in hydration has been reported on the assembly
of other lipoplexes [8,35].
A small red spectral shift is also observed for DNA/DODAB:MO (2:1)
at CRs (+/−) below 0.5, with the appearance of a blue shoulder on the
emission spectra of Nile Red. In the lipid systems without DNA, it was
found that the blue shoulder magnitude of the Nile Red spectra in-
creased with the DODAB content, following the order DODAB:MO
(0:1) b (1:2) b (1:1) b (2:1) b (1:0). This behavior is related to the
fact that the lamellar structures are favored at high DODAB contents,
which implies a less polar surrounding environment of the probe [25].
In the presence of DNA, and at comparable lipid concentrations, the
structural differences between the mentioned systems are much less
pronounced, and above CR (+/−) = 0.5 the spectral shape is constant
and the blue shoulder is almost lost. The red shift and the shape of the
spectrum for DODAB:MO (2:1) at very small charge ratios suggest
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gel phase [33]. Since this feature was not observed in the absence of
DNA [25], it seems that when MO content is low, DODAB-rich domains
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Fig. 3. Fluorescence emission spectra of Nile Red inDNA/DODAB:MO lipoplexeswith differentD
1.00; and D — 2.00).to increase of lipid content or due to lipoplex restructuring, as can be ob-
served in Fig. 3B and C.
In order to gain further insight on the type of structural changes that
occur upon variation on MO content and total lipid concentration, we525 550 575 600 625 650 675 700 725 750
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ODAB:MOmolar ratios (2:1, 1:1 and 1:2) and charge ratios (+/−) (A— 0.20; B— 0.50; C—
2560 J.P.N. Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2555–2567have also studied Nile Red ﬂuorescence anisotropy in DNA/DODAB:
MO lipoplexes. Fluidity is an important biophysical parameter to
characterize lipid bilayers in the absence and presence of DNA,
which is related to the release of the DNA into the mammalian
cells [36]. Thus, the ability of a lipid to form stable liposomes
(and stable lipoplexes) ought to be regarded along with anisotropy
measurements. Fluorescence anisotropy can provide information
on the microviscosity/ﬂuidity of the lipoplexes, because as the sys-
tem becomes more ﬂuid, the degree of rotation of the excited
ﬂuorophore placed within the system increases, and, accordingly,
the anisotropy decreases. The use of a two-state model gives
more localized information through Nile Red solvation cage dy-
namics. As already mentioned in Section 2.4, this two-state
model involves a solvent relaxed excited state (B*) and an initial
excited state (A*), but each one of these states can reﬂect an over-
lapping of different environments and structures. Supplementary
Fig. 2 illustrates, for the DNA/DODAB:MO (1:1) system, the results
of Nile Red ﬂuorescence anisotropy modeling, showing the recov-
ered theoretical anisotropies (rt) with the experimental values
(re). A good correspondence between the experimental results
and theoretical model was also obtained for Nile Red emission
spectra reconstructed from anisotropy data (Supplementary
Fig. 3), according to Eq. (2).
Fig. 4 represents the recovered theoretical anisotropies for DNA/
DODAB:MO lipoplexes with different molar ratios (2:1, 1:1 and 1:2)550 560 570 580 590 600 610 620 630 640 650
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Fig. 4. Variation of theoretical ﬂuorescence anisotropies (rt) of Nile Red in DNA/DODAB:MO lipo
(A— 0.20; B — 0.50; C — 1.00; and D — 2.00). Calculated rt values were determined through thand four different CRs (+/−) (A = 0.20; B = 0.50; C = 1.00; and
D = 2.00).
It is well known that the presence of helper lipids induces a decrease
in ﬂuorescence anisotropy, reﬂecting an increase in the ﬂuidity of
lipoplexes [36,37]. Similarly, regardless of the charge ratios tested, our
results show a general decrease in anisotropy with the increase in MO
content, indicating that the probe is located within the more ﬂuid
inverted non-lamellar MO domains when the helper lipid is present in
higher percentages. For CR (+/−) = 0.20 and the lowest MO content
in DNA/DODAB:MO(2:1) lipoplexes, a very high anisotropy is observed,
probably related to the previously reported formation of non-vesicular
structures [25] and also to the formation of the above mentioned
DODAB-rich domains. In Fig. 5, the recovered values for r1, r2, λ1, λ2
and f1 are plotted as a function of CR (+/−).
For all lipoplexes at CR (+/−) b 0.5, the values for r1 and r2 decrease
with MO content increase, conﬁrming the more ﬂuid environment of
MO domains in theMO rich lipoplexes. Although a decrease in both an-
isotropy components is observed, this is more evident on the r2 compo-
nent. The decrease in r2 component in DODAB rich lipoplexes, such as
DODAB:MO (2:1), is more pronounced than that reported in the ab-
sence of DNA in comparable total lipid concentrations (from 0.16 to
0.09) [25]. This is in agreement with a reported DNA ﬂuidization effect
on the lipoplexes [37]. It is proposed that, especially at temperatures
below phase transition, the interaction of the negatively charged DNA
backbone with the cationic lipid head groups can lead to a less tightly550 560 570 580 590 600 610 620 630 640 650
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2561J.P.N. Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2555–2567packed lipid structure [37]. Infrared studies also support this theory, and
suggest that the alignment of the lipid headgroups with DNA alters the
packing of the lipid molecules, increasing the conformational disorder
of lipid hydrocarbon tails [38]. Similar results have been reported for
other lipoplexes through NMR experiments, where it is shown that
DNA–lipid electrostatic interactions reduce the long-range lipid0.0 0.2 0.4 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0
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sperm DNA with different DODAB:MOmolar ratios (2:1, 1:1 and 1:2). Inset in section 6B: Size
used to attain charge ratio (+/−) 2.0, with the corresponding relative frequency percentagesmobility, but locally enhance the hydrocarbon chain dynamics by
perturbing the preferred lipid packing [39]. Fig. 5 also shows that, for
lipoplexes at CRs (+/−) N 0.5, although not as pronounced as for CRs
(+/−) b 0.5, the same trend is observed for r1, r2 and f1, i.e. an anisotro-
py decrease with the increase of MO content, conﬁrming the more ﬂuid
environment felt by Nile Red in the MO-rich lipoplexes.0.25 0.5 0.75 1.0 1.5 2.0
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2563J.P.N. Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2555–2567Overall, for the lipoplexes prepared at different CR (+/−), the an-
isotropy values obtained were less than 0.2–0.3, which are believed to
describe structure ﬂuid enough to result in an efﬁcient transfection
process [36,37].
The emission wavelength of the initially excited state (λ1)
shows an initial red shift with increasing CRs (+/−), followed by
stabilization (Fig. 5). These variations are consistent with the
trends shown by the blue shoulder of the emission spectra in
Fig. 3, due to the existence of pre-vesicular structures already
seen in the absence of DNA [25].
The λ1 values also show a red shift with increasing MO content,
which follows the same trend as observed in the absence of DNA [25].
This indicates that, despite sensing less hydration by being deeper locat-
ed at the MO domains (as concluded from the increase on the emission
intensity in Fig. 3), Nile Red reports a polarity increase with higher MO
content, probably by the exposition of the probe to the hydroxyl groups
of MO. Nevertheless, all maximum emission wavelengths (λ1 and λ2)
are blue shifted when compared with corresponding systems without
DNA, revealing a more hydrophobic environment sensed by the probe.
This is in agreementwith the observed increase of Nile Red ﬂuorescence
uponDNA interaction, explained by the alreadymentionedDNA coating
effect, which reduces the exposition of the probe to the more hydrated
environment. The maximum emission wavelength of the relaxed excit-
ed state (λ2) shows much less dependence on MO content when com-
pared with λ1. This result was already expected, as the relaxed excited
state (λ2) reports for the relaxed “solvent” cage of Nile Red, which is
not so sensitive to MO content.3.2. The effect of MO content on the structural dynamics of DNA/DODAB:
MO lipoplexes
Dynamic Light Scattering (DLS) gives information on the aver-
age size of the lipoplexes, while 90° Static Light Scattering (90°
SLS) provides information about the structure of the lipoplexes.
This information can be obtained when the intensity of scattered
light for DNA/DODAB:MO lipoplexes (ID) is divided by the intensity
of scattered light for DODAB:MO aggregates at the equivalent lipid
concentration (ID0) [40].
Fig. 6A shows the variation on intensity of static scattered light with
CR (+/−), for different DNA/DODAB:MO (2:1, 1:1 and 1:2) lipoplexes.
A different scattering behavior is observed for the three systems with
the increase of CR (+/−). Fig. 6B presents the particle mean size
(nm), determined by Dynamic Light Scattering (DLS), for the same
DNA/DODAB:MO lipoplexes. Although at charge neutralization point
CR (+/−) = 1.0 the average size of the lipoplexes increases with MO
content, after the neutralization point all three formulations present
similar sizes, which are comparable to the size of free liposomes (inset
of Fig. 6B). It is interesting to note that free liposomes present a bimodal
distribution, with an overall general size increase [(fA∙population A) +
(fB∙population B)] with MO content. This trend is similar to the size ob-
tained for the same aggregates containing DNA at CR (+/−) = 1.0, al-
though in the lipoplexes the size distribution is unimodal.
Below CR (+/−)= 0.5, where Nile Red has not yet felt the DNA/cat-
ionic lipid assembly and restructuring, a more dispersive behavior for
the systems with higher MO content is seen (Fig. 6A). This is in agree-
ment with the size of the free liposomes (inset of Fig. 6B) and indicates
that in this region there are mainly DODAB:MO structures coated with
DNA [41], and the DNA compaction has not occurred yet. After this CR
(+/−), the DNA-liposome surface interaction creates packing con-
straints and defects in the bilayers, triggering extensive interactionsFig. 7. Cryo-TEMmicrographs of DNA/DODAB:MO lipoplexes CR (+/−) = 4.0 (1 mM total lipi
Fast Fourier Transform (FFT) diagrams and gray-plot proﬁles for speciﬁed zones of the images, i
mains in the structures of the lipoplexes. A — DNA/DODAB:MO (1:2); B — DNA/DODAB:MO (1between adjacent bilayers. At this stage, clustering of the DNA coated
DODAB:MO structures is expected to occur. This originates two oppos-
ing effects on light scattering intensity, as can be seen in Zimmequation
(Eq. 14), which is valid for particles with size comparable to the wave-
length of light [42]:
Rθ ¼
r2
V 1þ cos2 2θð Þ  II0
 
¼ 8π
4α2
λ4
 N
0
 1−16π
2R2G sin
2 θð Þ
3λ2
 !
ð14Þ
where (V) is the volume of solution under observation, (I/I0) represents
the fraction of scattered light at an angle of (2θ), (r) is the distance be-
tween the sample and the detector, (RG) is particle's radius of gyration,
(α) represents the particle polarizability which is related to the
particle's volume and (N′) is the number density of particles.
The concentration of scattering particles decreases as a result of clus-
tering, whereas the size of the particles increases. From Eq. (14), it is de-
ducible that the effect of particle enlargement upon clustering should
originate an increase in light scattering. The clusters are intermediate
structures that originate the ﬁnal lamellar, hexagonal or inverted
bicontinuous cubic structure-based lipoplexes. Alongwith this structure
formation, the collapse of various liposomes also results in the release of
their interior aqueous contents. If the condensed lipoplex has the same
size as the liposome, a decrease of light scattering intensity is expected
as a result of less number of particles. But if the lipoplexes are much
larger than liposomes, the result is an increased light scattering.
The sudden increase of aggregate size seen in Fig. 6B near the charge
neutralization point is probably a consequence of the above described
clustering mechanism, and the subsequent decrease of aggregate size
indicates the condensation and restructuring of the lipoplexes. From
Fig. 6B, it is possible to conclude that, in systems with DODAB:MO
(1:1 and 1:2), the DNA coated liposome clusters are sufﬁciently big to
result in a peaked behavior in 90° SLS. This peaked behavior is less pro-
nounced in the case of DODAB:MO (2:1), where only a slight decrease
on scattered light intensity is observed. The different behavior of (2:1)
systemwas already observed for CRs (+/−) b 0.5 in Fig. 3A,with the ap-
pearance of a red shift that changes the shape of Nile Red spectrum
when compared to other DODAB molar ratios (1:1 and 1:2). This red
shift was previously reported for the same lipid systems in the absence
of DNA [25], where a highly dispersive region was documented for
lower DODAB:MO concentrations.
Cryo-TEM micrographs of DNA/DODAB:MO (1:2) lipoplexes CR
(+/−) = 4.0 are shown in Fig. 7. A further increase on MO content
was performed, forming DNA/DODAB:MO (1:4), to better observe
the effect of the helper lipid on the structures of the lipoplexes. By
increasing the MO content from DNA/DODAB:MO (1:2) to (1:4),
lipoplexes seem to preferentially adopt a non-lamellar phase with
inverted structures identiﬁed previously as MO-rich domains. The
superimposition of lamellar and inverted structures can be ob-
served by the double pattern of the Fast Fourier Transform (FFT)
proﬁles shown in Fig. 7. These MO-rich zones (depicted by the
white arrows) become even more visible at DODAB:MOmolar frac-
tions higher than (1:2), where lipoplexes present a more globular
and homogeneous shape/structure. The inter-lamellar distance
measured on micrographs (6 nm for the highest MO content) is
within the range of what has been determined in other MO
enriched lipid systems containing DNA (5.5–6 nm) [20]. Therefore,
in agreement with previously published SAXS analysis, the addi-
tion of DNA to positively charged membranes enriched with higherd) prepared by one-step addition of cationic vesicles to DNA at 25 °C, complemented with
ndicatedwith white dashed lines.White arrows indicate possible locations of MO-rich do-
:4).
2564 J.P.N. Silva et al. / Biochimica et Biophysica Acta 1838 (2014) 2555–2567MO contents seems to exert a templating effect on the lyotropic
phase, with the formation of non-lamellar phases (presumably
inverted hexagonal phases), once ﬁtting DNA in the inverted
cubic phase (typical of MO) would incur in large energetic cost
[20].
The information gathered with DLS, SLS and cryo-TEM suggests
that the structure of the lipoplexes formed is dependent on the
structure of the free DODAB:MO aggregates, that are dependent
on the exact DODAB:MO molar fraction. A model representing the
structure of the DODAB:MO DNA-lipoplexes is suggested in Fig. 8.
In DODAB-enriched formulations (DODAB:MO (4:1 and 2:1)),
where lamellar liposomes are prevalent, the encapsulation of DNA
will maintain the lamellar phase, and a multilamellar structure will
predominantly be formed, with the anionic nucleic acids sandwiched
between the lipid membranes. In MO-enriched formulations
(DODAB:MO (1:1 and 1:2)), where a coexistence of lamellar and
non-lamellar aggregates was observed [24], the encapsulation of
DNA will originate a DODAB lamellar phase enclosing the MO non-
lamellar phases, where the DNA will preferentially localize. Several
biophysical studies [20,39,43,44] also support two possible models
for the structure of lipoplexes, depending on the percentage of helper
lipid.
Therefore, as represented in Fig. 8, distinct nanoscale structures of
DNA-lipoplexes might be formed according to the DODAB:MO lipo-
somes used to encapsulate the DNA: DNA/DODAB:MO (4:1, 2:1)
lipoplexes exhibit a multilamellar organization with DNA ﬁlaments
stacked between adjacent lipid bilayers while DNA/DODAB:MO (1:1
and 1:2) may bring about the coexistence of aggregates with lamellar
and non-lamellar phases [19].
3.3. Effect of pH and anionic/neutral lipids on DNA dissociation from
lipoplexes with different structure (lamellar/non-lamellar)
The level of lipoplex condensation and destabilizationwas also eval-
uated through FRET dependence on the relative distance between the
DNA intercalating probe BOBO-1 and the lipid probe Rhodamine-
DHPE (Fig. 9).
The addition of DODAB:MO cationic liposomes to DNA causes a lin-
ear increase of FRET efﬁciency with CR (+/−) until a plateau value is
reached (Fig. 9A, B and C), where lipoplexes are formed and have its
highest degree of compaction. The plateau value is reached at CR
(+/−) = 2.0 for DNA/DODAB:MO (2:1) lipoplexes, CR (+/−) = 1.5
for DNA/DODAB:MO (1:1) lipoplexes and CR (+/−) = 1.0 for DNA/
DODAB:MO (1:2) lipoplexes, which shows the ﬂuidizing effect of MO
within the lipoplex structure (already observed by Nile Red anisotropy
measurements, Fig. 5), in agreement to the previously reported studies
[19,23]. The ﬁnal FRET efﬁciency (ϕFRET) obtained for all DNA/DODAB:
MO lipoplexes at CR (+/−) = 4.0 shows a clear distinction between
MO-rich formulations (1:2), with a ϕFRET of 90%, and DODAB-rich for-
mulations (2:1), with a ϕFRET of 70%. The higher efﬁciency energy trans-
fer for the MO-rich lipoplexes may reﬂect a close proximity between
donor and acceptor, associated with the presence of a more ﬂuid non-
lamellar phase at higher MO contents (Fig. 8).
After cellular uptake via endocytosis, DNA lipoplexes must escape
from endosomes so that DNA can progress toward the cell nucleus.
Only a certain amount of time is available for this, since the endosomal
pathway involves degradation of the endosome contents: initially
through pH reduction and then through fusion with low pH lysosomes
[5]. As the endosomal escape is known to be the main intracellular bar-
rier for efﬁcient cell transfection, it is interesting to evaluate the in vitro
degree of lipoplex destabilization at relevant conditions such as: pH de-
crease (Fig. 9A′, B′ and C′) and interaction with anionic/neutral lipids
(Fig. 9A″, B″ and C″). The initial pH decrease from 7.4 to 6.0 leads to a
slight increase on the ionic strength of the medium, contributing to a
higher compaction of all DNA/DODAB:MO lipoplexes prepared at CR
(+/−) = 4.0. This compaction is noticed by the smooth increase onϕFRET observed for all formulations. After this point, and until pH 4.0, a
plateau is reached, followed by a decrease on ϕFRET that could be ex-
plained by some lipoplex degradation. This effect is less evident for
lipoplexes with high MO content, due to their higher stability [19].
The stability of MO richer lipoplexes is probably due to the presence
of non-lamellarMO phases (Fig. 8). These non-lamellar inverted phases
together with the cationic charge conferred by DODAB allow improved
entrapment of nucleic acids which are strongly conﬁned within the
aqueous domains of hexagonal cylinders stabilized by electrostatic
bonds to DODAB positive charges and by hydrogen bonds with the
water andMOheadgroups. The same kind of rational has beenproposed
by other authors when explaining the conﬁnement of DNA into MO
enriched lipoplexes [45]. This stabilization effect makes the MO
enriched formulations as more reliable for the encapsulation and pro-
tection of DNA assuring less lipoplex degradation inside the endosome.
As a downside of the stability of the MO enriched lipoplexes is the DNA
slow release, as such a strong conﬁnement of theDNAat thewater–lipid
interface prevents its release into the excess water [45]. The interaction
of DNA/DODAB:MO (2:1, 1:1 and 1:2) lipoplexes at CR(+/−) = 4.0
with the lipid surfactants OA, DOPA, DOPS and DOPE revealed that the
uncharged phospholipid (DOPE) and the monovalent anionic phospho-
lipids (DOPS) and (DOPA) poorly affect FRET efﬁciency, irrespective of
theMOcontent in the lipoplexes. This suggests that the tested phospho-
lipids have a limited inﬂuence on the lipoplex structure destabilization.
Contrastingly, the fatty acid OA has a strong effect on the structural or-
ganization of DNA/DODAB:MO lipoplexes at a wide range of
concentrations.
When up to 25 μMof OA concentration is added to DNA/DODAB:MO
(2:1 and 1:1) lipoplexes, a decrease inϕFRET occurs, indicating a destabi-
lization of the lamellar phase of the lipoplexes, similar to the already ob-
served for DODAB/OA mixed systems in the absence of DNA [46]. This
destabilization occurs by the formation of planar bilayer fragments
and the release of DNA from the lipoplex. For DNA/DODAB:MO (1:2
and 1:4) lipoplexes with the same OA concentration (25 μM), a slower
and smaller FRET decrease is observed, suggesting a swelling of the
lipoplex structure due to the diffusion of OA and a consequent stabiliza-
tion of the inverted non-lamellar structures [47,48].
The gathered results suggest that the higher the MO content, the
more stable the lipoplex, since the enrichedMO lipoplex were more re-
sistant to the degradation imposed by extreme pH conditions, and also
to OA destabilization.
3.4. How lamellar versus inverted non-lamellar phases affect transfection
efﬁciency of DNA/DODAB:MO lipoplexes
The structural variations discussed in the previous sections are
reﬂected on the ﬁnal transfection efﬁciency of DNA/DODAB:MO
lipoplexes, as can be observed in Fig. 10.
Both non-lamellar and lamellar phases of the lipoplexes have an im-
portant role, and thebalance between these twophaseswill be determi-
nant for a more effective transfection. Lamellar phases can provide
closer lipoplex–cell surface interaction, which is a crucial initial event
for the lipoplex transfection [8]. Fig. 10 shows that DNA/DODAB:MO
(2:1)was themost efﬁcient lipoplex, with transfection efﬁciencies com-
parable to the commercial reagent Lipofectamine™ LTXwhen 1 μg DNA
is used. These results are in agreement to the above considerations, re-
inforcing the advantage of having lipoplexes with a multilamellar orga-
nization that provide a tight membrane interaction between the
lipoplex surface and the cellularmembrane [8]. Nevertheless, the higher
rigidity of this DODAB-rich lipid system results in a dose-effect re-
sponse, meaning that a superior amount of lipid and DNA is needed to
obtain transfection efﬁciencies comparable to Lipofectamine™ LTX.
Our results also demonstrate that the balance between lamellar and
non-lamellar phases can be tuned using different MO content in the
DODAB:MO lipoplexes. In this regard, the distribution of MO in the
lipoplexes is determinant to understand theﬁnal transfection efﬁciency.
Fig. 8. Schematic representation of the proposedmodel for the structures of DODAB:MO liposomes (upper ﬁgure) and the correspondent DNA-lipoplexes (lower ﬁgure). (A) DODAB:MO
(2:1)where the lamellar phase is predominant andMO iswithin theDODAB lamellar phase. (B)DODAB:MO(1:1 and 1:2)whereMOorganizes in invertednon-lamellar structures limited
by DODAB lamellar phase.
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membrane charge density (σM) [49] would be 0.008 e/Ǻ2 and
0.0051 e/Ǻ2 for DNA/DODAB:MO (1:2) and (1:4) lipoplexes respective-
ly, compared with the already reported σM of 0.014 e/Ǻ2 and 0.010 e/Ǻ2
for DNA/DODAB:MO (2:1) and (1:1) lipoplexes [19]. However, these
membrane charge densities do not agree with the zeta-potential mea-
surements (data not shown), which indicates a non-homogeneous dis-
tribution of MO in the bilayers and corroborates the coexistence of
several aggregates with different MO contents, as proposed in Fig. 8
[24]. Different coexistent phases (lamellar and inverted non-lamellar)
have been reported to arise from cationic and helper lipids, resulting
in a smaller transfection efﬁciency [8].
Higher MO content induces the formation of non-lamellar inverted
domains with less hydration/microviscosity which are important fea-
tures promoting lipoplex assembly and increasing DNA cooperative col-
lapse. DNA is thus strongly conﬁned in these MO domains, and
consequently DNA/MO enriched lipoplexes are more stable and less
prone to pH and anionic lipids destabilization. The sensitivity of the
lipoplexes to OA destabilization is also dependent on MO, since
lipoplexes with lower MO content are more destabilized by OA than
lipoplexes with higher MO content. MO enriched formulations are
thusmore reliable for the encapsulation and protection of DNA assuring
less lipoplex degradation inside the endosome. However, such an ad-
vantage in terms of stability does not translate in higher transfection
rates of MO enriched lipoplexes. Indeed, in order to reach the levels of
transfection efﬁciency obtained by the lipoplexeswithmultilamellar or-
ganization, the CR (+/−) must be increased. In the case of DNA/
DODAB:MO (1:4) formulation, for example, increasing the CR (+/−)
to 6.0 is enough to obtain transfection efﬁciencies comparable to Lipo-
fectamine™ LTX (Fig. 10), without any signiﬁcant increase in the associ-
ated cytotoxicity (data not shown). The explanation to the less efﬁcient
transfection is probably related with the higher stability conferred by
the non-lamellar inverted phases (1:1, 1:2 and 1:4 formulations), that
are advantageous regarding DNA protection, but have a drawback of
hardening DNA release.
In general, MO as a helper lipid improves transfection efﬁciency by
facilitating endosomal escape of DNA. However, our results indicatethat high MO content causes less transfection when compared with
DODAB richer lipoplexes (at CR ≤ 4.0). The distribution of MO in the
DODAB:MO lipoplexes plays a determinant role in this matter. Nile
Red probe senses the more ﬂuidic environment of MO inverted non-
lamellar domains of DODAB:MO (1:1 and 1:2) and the recent work cor-
roborates the ﬂuidity effect of increasingMO content by differential cal-
orimetry studies [50]. It was expected that the higher ﬂuidity of
enriched MO lipoplexes would imply a higher fusogenicity of the parti-
cles, butMO is preferentially located inside of the lamellarDODAB struc-
tures, being less accessible to interact with the endosomes and promote
fusion. In agreement to this assumption, it has been reported that MO-
enriched liposomes (DODAB:MO (1:2)) did not promote a markedly
fusogenic effect on endosome models compared to other systems with
less MO (DODAB:MO (2:1)) [50]. Hence, the small fusogenic capacity
associated with the tight DNA binding may justify the less transfection
efﬁciency of MO enriched lipoplexes.
To sum up, formulations of DODAB containing MO as helper lipid
present different properties and transfection efﬁciencies according to
the MO content. Low MO contents have a similar gene silencing ability
as the commonly used helper lipid 1,2-dioleyl-3-phosphatidylethanol-
amine (DOPE), but with much lower cytotoxicity [50]. Thus the intro-
duction of MO as lipid helper is able to decrease the toxicity without
compromising the efﬁciency of lipofection. Higher MO contents com-
promise the transfection efﬁciency that requires higher CR (+/−), but
present the advantage of higher stability and possibility of co-
encapsulation of drugs in MO enriched domains, providing a synergic
drug/genetic therapy.
4. Conclusions
This work describes the effect of MO content on the structure and
physicochemical properties of pDNA/DODAB:MO lipoplexes and estab-
lishes correlations with their transfection efﬁciency. The advantage of
usingMO as helper lipid is undeniable, as it is less toxic than other help-
er lipids like DOPEwith similar gene silencing ability. However, increas-
ing MO content at ratios of DODAB:MO equal or higher than 1:1 lowers
the transfection efﬁciency. Therefore the content of MO can be tuned
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Fig. 9. Förster Resonance Energy Transfer (470–700 nm, λexc = 460 nm) of donor/acceptor pair BOBO-1/rhodamine-DHPE in DNA/DODAB:MO lipoplexes ([Phosphate] = 2 mM) at dif-
ferent charge ratios (+/−) (A, B, C, including their respective ﬂuorescence spectra), upon incubation at different pHs andwith different concentrations of neutral/anionic lipids (A′, B′, C′).
Solid symbols represent the variation in the Förster resonance energy transfer efﬁciency (ϕFRET) calculated through Eq. (12) between BOBO-1 and rhodamine-DHPE species. The DNA in-
tercalating probe BOBO-1was used at probe/phosphate ratio of 1/200 and the lipid probe rhodamine-DHPEwas used at probe/lipid ratio of 1/200. A—DNA/DODAB:MO (2:1) at different
CRs (+/−); B — DNA/DODAB:MO (1:1) at different CRs (+/−); C — DNA/DODAB:MO (2:1) at different CRs (+/−); A′ — DNA/DODAB:MO (2:1) CR (+/−) = 4.0 at different pHs and
different concentrations of anionic lipids; B′ — DNA/DODAB:MO (1:1) CR (+/−) = 4.0 at different pHs and different concentrations of anionic lipids; C′ — DNA/DODAB:MO (2:1) CR
(+/−) = 4.0 at different pHs and different concentrations of anionic lipids.
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er uses DODAB:MO systems with less content of MO it will achieve
higher transfection rates and a controlled release of the nucleic acids,
whereas the use of higher content ofMO (DODAB:MO N (1:1)) requires
higher CR (+/−) to reach the same transfection efﬁciency. Nonetheless,Negative Control
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Fig. 10.Reporterβ-galactosidase activity 48 h after transfection of 293T cellswith different
cationic lipoplexes (CRs (+/−) = 2.0, 4.0 and 6.0) prepared by one-step addition of cat-
ionic vesicles to pDNA (0.5 and 1.0 μg pDNA per well, white and light gray, respectively).
Control: cells incubatedwith free pDNA. Themean (+/−) SDwas obtained from three in-
dependent experiments.MO enriched systems still reach very acceptable transfection rates and
they bear other advantages, such as an increased stability (preventing
the immediate release of nucleic acid) and the possibility to co-
encapsulate drugs in MO non-lamellar inverted domains providing a
combined gene and drug therapy.
Current ongoing strategies for the optimization of the MO-enriched
systems are the inclusion of a third lipid which enhances DNA release
without affecting the stability of the lipoplex structure.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2014.06.014.
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